Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP6 binds USP9X, KMT2B, SETD2, and PMS1. 1 / 1

| 1

➶

sparser

"Group 1 (LP1, OPM2, SKMM2, XG26, XG23, XG24, L363, XG1, XG16, XG12, and XG13) is mainly characterized by NRAS , CNOT3 and LRP1B mutated (MUT) and KRAS , MN1 , ATM , USP6 and KMT2B wild type (WT) genes; group 2 (XG25 and XG7) is associated with mutations in PMS1 , USP6 , SETD2 , KMT2B and FAM46C ; group 3 (RPMI, XG11, XG29, Lopra, XG27, MM1S, AMO1, XG20, and XG6) is mainly characterized by the presence of mutations in KRAS , ATM and MN1 as well as CNOT3 WT; group 4 (XG19, JJN3, XG2, and XG28) is characterized by KMT2B mutations; cell lines of group 5 (MOLP8, XG5, MOLP2, and XG30) were associated with mutations in MAP3K1 , EZH2 and SETD2 (Figure xref A)."

30809292

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...